Compare Smith & Nephew plc (SNN) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Toronto-Dominion Bank — how do they compare? Smith & Nephew plc trades at $27.96 (market cap $11.62B), while Toronto-Dominion Bank trades at $119.14 (market cap $195.86B). The key difference: Toronto-Dominion Bank is far larger — about 16.9× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.86%). Which is the better fit depends on your goals.
| SNN | TD | |
|---|---|---|
Market Cap | $11.62B | $195.86B |
Sector | Health | Financials |
52-Week High | $38.53 | $124.80 |
52-Week Low | $27.80 | $75.86 |
Enterprise Value | $14.66B | — |
Dividend Yield | 2.86% | 2.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SNN trades at $27.87, down 3.46% today and near a 52-week low. Technical indicators are bearish, but oversold RSI levels suggest potential for a rebound. Fundamentally, the company shows strong revenue growth to $6.16 billion in 2025 and a net income margin of 10.08%, though recent guidance cuts and CFO departure have weighed on sentiment. A dividend of $0.31 is scheduled for payment in November 2026.
The outlook is cautious due to competitive pressures and execution risks, but valuation metrics like a P/E of 18.96 appear reasonable. Analyst consensus is Hold, with 65% recommending neutrality. Upside depends on improved operational performance and stabilization in key markets.
TD stock trades at $120.52, down 0.91% today, with a neutral technical signal. The company reported strong Q3 2026 earnings, beating estimates with a profit of $4.62 billion, driven by capital markets and cost controls. Revenue growth is steady, with 2025 revenue at $61.28 billion and net income margin of 24.88%. Analyst consensus is bullish with 9 buy ratings and no sells. Recent news highlights AI value generation and participation in tokenized payments tests.
Outlook remains positive given earnings momentum and dividend stability, but risks include high debt levels and macroeconomic sensitivity. The stock offers value with a P/E of 17.85 and consistent dividend payments, though competition and interest rate fluctuations pose challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
